Comparison of FDA Approved Kinase Targets to Clinical Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of FDA Approved Kinase Targets to Clinical Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks
Authors
Keywords
-
Journal
Biomed Research International
Volume 2016, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2016-07-29
DOI
10.1155/2016/2509385
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia
- (2016) M. Bellon et al. BLOOD
- EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape
- (2016) S.-O. Lim et al. CANCER RESEARCH
- Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
- (2016) Peng Wu et al. DRUG DISCOVERY TODAY
- Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study
- (2016) Weiwei Xue et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- New Frontiers in Druggability
- (2015) Dima Kozakov et al. JOURNAL OF MEDICINAL CHEMISTRY
- The genomic landscape of response to EGFR blockade in colorectal cancer
- (2015) Andrea Bertotti et al. NATURE
- Orchestrating high-throughput genomic analysis with Bioconductor
- (2015) Wolfgang Huber et al. NATURE METHODS
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- KEGG as a reference resource for gene and protein annotation
- (2015) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information
- (2015) Hong Yang et al. NUCLEIC ACIDS RESEARCH
- FDA-approved small-molecule kinase inhibitors
- (2015) Peng Wu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Mutational profiling of kinases in glioblastoma
- (2014) Fonnet E Bleeker et al. BMC CANCER
- Advances in kinase targeting: current clinical use and clinical trials
- (2014) Mathias Rask-Andersen et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Druggability of the enzymes of the non-mevalonate-pathway
- (2013) Tiziana Masini et al. DRUG DISCOVERY TODAY
- Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locations
- (2012) Woody Han et al. CANCER LETTERS
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- (2012) Sandra Misale et al. NATURE
- Emerging therapeutic targets in endometrial cancer
- (2011) Konstantin J. Dedes et al. Nature Reviews Clinical Oncology
- Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery
- (2011) F. Zhu et al. NUCLEIC ACIDS RESEARCH
- Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinoma
- (2010) Brian I. Rini CANCER
- Biochemical network-based drug-target prediction
- (2010) Edda Klipp et al. CURRENT OPINION IN BIOTECHNOLOGY
- Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery
- (2010) Stéphanie Pérot et al. DRUG DISCOVERY TODAY
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
- (2010) Klaus Strebhardt NATURE REVIEWS DRUG DISCOVERY
- Network medicine: a network-based approach to human disease
- (2010) Albert-László Barabási et al. NATURE REVIEWS GENETICS
- Database resources of the National Center for Biotechnology Information
- (2010) E. W. Sayers et al. NUCLEIC ACIDS RESEARCH
- Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway
- (2010) S Murayama-Hosokawa et al. ONCOGENE
- Binding-Site Assessment by Virtual Fragment Screening
- (2010) Niu Huang et al. PLoS One
- In vivo target validation using gene invalidation, RNA interference and protein functional knockout models: it is the time to combine
- (2009) Olivier Vidalin et al. CURRENT OPINION IN PHARMACOLOGY
- What Are Next Generation Innovative Therapeutic Targets? Clues from Genetic, Structural, Physicochemical, and Systems Profiles of Successful Targets
- (2009) F. Zhu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Target profiling of small molecules by chemical proteomics
- (2009) Uwe Rix et al. Nature Chemical Biology
- Kinase mutations in human disease: interpreting genotype–phenotype relationships
- (2009) Piya Lahiry et al. NATURE REVIEWS GENETICS
- Update of TTD: Therapeutic Target Database
- (2009) Feng Zhu et al. NUCLEIC ACIDS RESEARCH
- Human Disease-Drug Network Based on Genomic Expression Profiles
- (2009) Guanghui Hu et al. PLoS One
- TissueDistributionDBs: a repository of organism-specific tissue-distribution profiles
- (2009) Sunitha Kogenaru et al. THEORETICAL CHEMISTRY ACCOUNTS
- Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints
- (2008) D Llobet et al. JOURNAL OF CLINICAL PATHOLOGY
- NCBI BLAST: a better web interface
- (2008) M. Johnson et al. NUCLEIC ACIDS RESEARCH
- Quantitative systems-level determinants of human genes targeted by successful drugs
- (2007) L. Yao et al. GENOME RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started